FDA Approves Interchangeable Biosimilar for Multiple Inflammatory Diseases

The FDA approved Wezlana, an interchangeable biosimilar to Stelara for multiple inflammatory diseases.

Source: FDA Center for Drug Evaluation and Research - What's New - October 31, 2023 Category: Drugs & Pharmacology Authors: FDA Source Type: news